alsterpaullone and Epstein-Barr-Virus-Infections

alsterpaullone has been researched along with Epstein-Barr-Virus-Infections* in 1 studies

Other Studies

1 other study(ies) available for alsterpaullone and Epstein-Barr-Virus-Infections

Article	Year
Antitumor activity of cyclin-dependent kinase inhibitor alsterpaullone in Epstein-Barr virus-associated lymphoproliferative disorders. Cancer science, 2020, Volume: 111, Issue:1 Epstein-Barr virus (EBV) is a well-established tumor virus that has been implicated in a wide range of immunodeficiency-associated lymphoproliferative disorders (LPDs). Although rituximab, a CD20 mAb, has proven effective against EBV-associated LPDs, prolonged use of this drug could lead to resistance due to the selective expansion of CD20 Topics: Animals; Antineoplastic Agents; Apoptosis; Benzazepines; Cell Cycle Checkpoints; Cell Line; Cyclin-Dependent Kinase 2; Epstein-Barr Virus Infections; G1 Phase; HEK293 Cells; Herpesvirus 4, Human; Humans; Indoles; Lymphoproliferative Disorders; Mice; Mice, Inbred NOD; Protein Kinase Inhibitors	2020

Article

Year

Antitumor activity of cyclin-dependent kinase inhibitor alsterpaullone in Epstein-Barr virus-associated lymphoproliferative disorders.

Cancer science, 2020, Volume: 111, Issue:1

Epstein-Barr virus (EBV) is a well-established tumor virus that has been implicated in a wide range of immunodeficiency-associated lymphoproliferative disorders (LPDs). Although rituximab, a CD20 mAb, has proven effective against EBV-associated LPDs, prolonged use of this drug could lead to resistance due to the selective expansion of CD20

Topics: Animals; Antineoplastic Agents; Apoptosis; Benzazepines; Cell Cycle Checkpoints; Cell Line; Cyclin-Dependent Kinase 2; Epstein-Barr Virus Infections; G1 Phase; HEK293 Cells; Herpesvirus 4, Human; Humans; Indoles; Lymphoproliferative Disorders; Mice; Mice, Inbred NOD; Protein Kinase Inhibitors

2020